カルナバイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/07 | 1,230 | 1,258 | 1,230 | 1,255 | +28 | +2.3% | 23,000 |
2021/06/04 | 1,233 | 1,238 | 1,222 | 1,227 | -10 | -0.8% | 24,400 |
2021/06/03 | 1,230 | 1,250 | 1,230 | 1,237 | -13 | -1% | 16,900 |
2021/06/02 | 1,245 | 1,256 | 1,230 | 1,250 | -7 | -0.6% | 14,300 |
2021/06/01 | 1,228 | 1,260 | 1,224 | 1,257 | +39 | +3.2% | 40,600 |
2021/05/31 | 1,220 | 1,233 | 1,214 | 1,218 | -27 | -2.2% | 51,700 |
2021/05/28 | 1,250 | 1,250 | 1,228 | 1,245 | -7 | -0.6% | 37,800 |
2021/05/27 | 1,260 | 1,264 | 1,242 | 1,252 | -8 | -0.6% | 16,100 |
2021/05/26 | 1,265 | 1,269 | 1,255 | 1,260 | -4 | -0.3% | 10,500 |
2021/05/25 | 1,230 | 1,268 | 1,230 | 1,264 | +44 | +3.6% | 27,300 |
2021/05/24 | 1,237 | 1,239 | 1,213 | 1,220 | -25 | -2% | 18,100 |
2021/05/21 | 1,236 | 1,252 | 1,236 | 1,245 | +9 | +0.7% | 11,300 |
2021/05/20 | 1,229 | 1,243 | 1,226 | 1,236 | +1 | +0.1% | 12,500 |
2021/05/19 | 1,224 | 1,243 | 1,221 | 1,235 | +5 | +0.4% | 17,700 |
2021/05/18 | 1,217 | 1,239 | 1,217 | 1,230 | +1 | +0.1% | 19,500 |
2021/05/17 | 1,237 | 1,256 | 1,204 | 1,229 | -5 | -0.4% | 32,000 |
2021/05/14 | 1,216 | 1,253 | 1,216 | 1,234 | +21 | +1.7% | 44,800 |
2021/05/13 | 1,215 | 1,233 | 1,198 | 1,213 | -28 | -2.3% | 68,100 |
2021/05/12 | 1,271 | 1,292 | 1,226 | 1,241 | -43 | -3.3% | 111,600 |
2021/05/11 | 1,261 | 1,311 | 1,261 | 1,284 | +5 | +0.4% | 37,700 |
2021/05/10 | 1,282 | 1,294 | 1,270 | 1,279 | -12 | -0.9% | 57,700 |
2021/05/07 | 1,289 | 1,300 | 1,283 | 1,291 | -9 | -0.7% | 24,600 |
2021/05/06 | 1,289 | 1,312 | 1,285 | 1,300 | -12 | -0.9% | 37,600 |
2021/04/30 | 1,286 | 1,312 | 1,279 | 1,312 | +9 | +0.7% | 30,500 |
2021/04/28 | 1,318 | 1,318 | 1,287 | 1,303 | +9 | +0.7% | 39,900 |
2021/04/27 | 1,316 | 1,316 | 1,288 | 1,294 | +2 | +0.2% | 27,100 |
2021/04/26 | 1,300 | 1,320 | 1,291 | 1,292 | -19 | -1.4% | 29,800 |
2021/04/23 | 1,278 | 1,323 | 1,266 | 1,311 | +31 | +2.4% | 55,500 |
2021/04/22 | 1,243 | 1,280 | 1,243 | 1,280 | +36 | +2.9% | 24,700 |
2021/04/21 | 1,260 | 1,266 | 1,234 | 1,244 | -21 | -1.7% | 40,700 |
2021/04/20 | 1,268 | 1,278 | 1,256 | 1,265 | -18 | -1.4% | 30,800 |
2021/04/19 | 1,275 | 1,287 | 1,267 | 1,283 | +8 | +0.6% | 21,900 |
2021/04/16 | 1,282 | 1,295 | 1,275 | 1,275 | -4 | -0.3% | 18,900 |
2021/04/15 | 1,280 | 1,289 | 1,264 | 1,279 | -6 | -0.5% | 53,500 |
2021/04/14 | 1,285 | 1,291 | 1,278 | 1,285 | -2 | -0.2% | 27,200 |
2021/04/13 | 1,297 | 1,301 | 1,285 | 1,287 | -10 | -0.8% | 19,400 |
2021/04/12 | 1,298 | 1,304 | 1,285 | 1,297 | -1 | -0.1% | 32,000 |
2021/04/09 | 1,299 | 1,319 | 1,295 | 1,298 | +7 | +0.5% | 49,300 |
2021/04/08 | 1,330 | 1,330 | 1,280 | 1,291 | -36 | -2.7% | 92,800 |
2021/04/07 | 1,336 | 1,337 | 1,319 | 1,327 | -17 | -1.3% | 38,400 |
2021/04/06 | 1,355 | 1,359 | 1,338 | 1,344 | -5 | -0.4% | 24,900 |
2021/04/05 | 1,357 | 1,357 | 1,340 | 1,349 | -8 | -0.6% | 20,800 |
2021/04/02 | 1,370 | 1,370 | 1,350 | 1,357 | -3 | -0.2% | 19,100 |
2021/04/01 | 1,354 | 1,373 | 1,346 | 1,360 | +6 | +0.4% | 40,400 |
2021/03/31 | 1,346 | 1,376 | 1,345 | 1,354 | -7 | -0.5% | 22,200 |
2021/03/30 | 1,346 | 1,370 | 1,344 | 1,361 | +14 | +1% | 32,400 |
2021/03/29 | 1,390 | 1,390 | 1,345 | 1,347 | -16 | -1.2% | 43,600 |
2021/03/26 | 1,355 | 1,381 | 1,340 | 1,363 | +35 | +2.6% | 55,400 |
2021/03/25 | 1,330 | 1,357 | 1,314 | 1,328 | -15 | -1.1% | 65,400 |
2021/03/24 | 1,393 | 1,395 | 1,336 | 1,343 | -47 | -3.4% | 81,600 |
851~
900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
VIS | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 84,500円 | +240.0% | - | 0.00% | - | 2.75倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
市場注目の銘柄
チャート関連のコラム